VIDEO: Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and Sequencing
In this video, Dr. Joyce O’Shaughnessy discusses the treatment landscape for patients who progress on ET + CDK4/6 inhibitors, including the importance of biomarker testing in this setting.
Date of Last Review: May 07, 2024
Document Number: VV-MED-153059
Are you satisfied with this content?